Skip to main content

Table 2 Hematopoietic stem cell transplantation (HSCT) in patients positive or negative for CSF JCV

From: Characteristics of progressive multifocal leukoencephalopathy clarified through internet-assisted laboratory surveillance in Japan

Underlying disease

Proportion (%) of JCV-positive patientswith HSCT (n=27)

Proportion (%) of JCV-negative patientswith HSCT (n=68)

Acute myeloid leukemia

2/2

(100)

9/10

(90.0)

Acute lymphoblastic leukemia

1/1

(100)

4/6

(66.7)

Chronic lymphocytic leukemia

0/1

(0)

0/1

(0)

Adult T-cell leukemia

0/1

(0)

0/1

(0)

Hodgkin's lymphoma

1/1

(100)

0/1

(0)

Non-Hodgkin's lymphoma

1/6

(16.7)

5/21

(23.8)

Aplastic anemia

2/2

(100)

0/2

(0)

Primary immunodeficiency syndrome

0/2

(0)

1/6

(16.7)

Multiple myeloma

1/2

(50.0)

0/1

(0)

Primary macroglobulinemia

0/1

(0)

0/0

NA

Total

8/19

(42.1)

19/49

(38.8)

  1. NA, not applicable.